Navigation Links
Amneal Pharmaceuticals Receives US FDA Approval for Three Generic Prescription Drugs; Two Using New FDA Electronic Filing Format
Date:5/7/2008

PATERSON, N.J., May 7 /PRNewswire/ -- Amneal Pharmaceuticals is pleased to announce that it received US FDA approval to manufacture Primidone Tablets (50/250mg), Cyclobenzaprine Tablets (10mg) and Demeclocycline Tablets (150/300mg) within the last several weeks. Two of these products were filed during 2007 using the FDA's evolutionary eCTD/QbR/QOS format that enabled approvals in less than twelve months.

Demeclocycline HCl Tablets USP, in strengths of 150mg and 300mg, is an AB-Rated, therapeutically equivalent alternative to Declomycin(R) (a trademark of Stonebridge Pharma) and is indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in a number of conditions including Rocky Mountain spotted fever and respiratory tract infections.

Primidone Tablets USP, in strengths of 50mg and 250mg, an AB-Rated, therapeutically equivalent alternative to Mysoline(R) (a trademark of Valeant Pharmaceuticals) which, used alone or concomitantly with other anticonvulsants, is indicated in the control of grand mal, psychomotor, and focal epileptic seizures. It may control grand mal seizures refractory to other anticonvulsant therapy.

Cyclobenzaprine HCl Tablets USP, in 10mg strength, is an AB-Rated therapeutically equivalent alternative to FLEXERIL(R) (a trademark of McNeil Consumer Healthcare) and is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions.

These three products are Amneal's 15th, 16th and 17th ANDA (Abbreviated New Drug Application) approvals and continues to build the momentum for the aggressive growth Amneal has designed and is experiencing. All three products are shipping and will be sold directly to the trade as well as through wholesalers-distributors.

Separately, in December 2007 Amneal closed on the acquisition of a 30,000 sq ft liquid Rx manufacturing plant in New Jersey, completed constructi
'/>"/>

SOURCE Amneal Pharmaceuticals LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Amneal Pharmaceuticals & Indoco Remedies Finalize Long Term Joint Venture Agreement to Develop and Market Generic Ophthalmic Pharmaceuticals
2. Amneal Receives FDA Approval for Bethanechol Chloride Tablets, USP Using New Expedited FDA Approval Process
3. Agreement Executed for Amneal Pharmaceuticals to Acquire the Assets of Interpharm Holdings
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... April 17, 2015 John Evans, a ... on the Patio from 2 p.m. to 3 p.m. ... at 1320 Executive Ct. in Pekin, Illinois, serves older ... need some help to maintain their independence. , Becky ... tropical treats will be served during the luau. , ...
(Date:4/17/2015)... Florida Hospital Wesley Chapel, Florida Hospital at Connerton ... all selected as Top Workplaces in Tampa Bay. ... ranked number one for large businesses according to the ... partnership with an independent research firm. Florida Hospital Wesley ... in October of 2012 with a vision of excellence ...
(Date:4/17/2015)... 17, 2015 Representatives Jim Himes (D-CT) ... Treatment Act HR 1849 in congress on April 16, ... treatment for patients with the genetic disease. , ... would be the first to create a federally led ... of hereditary hemorrhagic telangiectasia. This would effectively prevent premature ...
(Date:4/17/2015)... York, New York (PRWEB) April 17, 2015 ... that allege this class of prescription medications ... a heart attack, stroke or other life-threatening cardiovascular ... underway in U.S. District Court, Northern District of ... by the U.S. Judicial Panel on Multidistrict Litigation ...
(Date:4/17/2015)... 2015 Connie Casad, M.D., a well-known ... advocate with 30 years of practice experience in Dallas, ... level of service for her patients with the availability ... recommended wellness books with a brief synopsis on each ... her interest in providing this service, Dr. Casad said, ...
Breaking Medicine News(10 mins):Health News:John Evans Supportive Living Community Prepares for Party on the Patio 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 2Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 3Health News:Tampa Bay Times Selects Florida Hospital Wesley Chapel, Florida Hospital at Connerton Long Term Acute Care and Florida Hospital Carrollwood As Top Workplaces in Tampa Bay 4Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 2Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 3Health News:Testosterone Treatment Lawsuits Increase, as New Report Indicates Over 200 Federal Cases Filed Since March 4Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2
... internally dynamized anterior cervical plating system offers zero-step ... Spine announces the nationwide market introduction of the ... which gained 510(k) approval from the U.S. Food ... an internally dynamizing anterior cervical plating ...
... Activeion Cleaning Solutions, LLC is ... its commitment to environmental sustainability by joining ... and businesses in the health care field ... footprints.(Logo: http://www.newscom.com/cgi-bin/prnh/20090519/MN19118LOGO )Practice Greenhealth provides ...
... 2009 CytoFlora decreases IgA and IgM antibodies to ... LAGUNA HILLS, Calif., May 19 It is believed that ... gastrointestinal dysfunction. BioRay,s new cell wall lysed probiotic, ... to correct microbial imbalances, drive pathogens out of the gastrointestinal ...
... crisis highlighted an unforseen by-product of the looming fuel ... such as plastics that society takes for granted but ... oil. Scientists are looking to microorganisms to pick ... according to research presented today at the 109th General ...
... See Clearly Now" Helps Readers Seek Deeper Meaning in ... Mary Soliel,s debut non-fiction, "I Can See Clearly Now: ... "Indie" Finalist in the "Spirituality" category of the 2009 ... Her book was previously selected by USA Book News ...
... New Life Agency filed suit against Beitler Services on ... out of a previous contractual relationship between New Life ... Once New Life Agency assumed direct management for claims ... Surrogate Maternity and Cycle Medical Plan(R), clients and surrogates.In ...
Cached Medicine News:Health News:Activeion Cleaning Solutions, LLC Joins National Health Organization Supporting Environmental Practices 2Health News:Activeion Cleaning Solutions, LLC Joins National Health Organization Supporting Environmental Practices 3Health News:BioRay's CytoFlora Reduces Digestive and Behavioral Issues in Autistic Children 2Health News:Microscopic manufacturers produce eco-friendly plastics 2Health News:Microscopic manufacturers produce eco-friendly plastics 3Health News:Author Mary Soliel Receives Third National Book Award for Debut Non-Fiction on Synchronicity 2Health News:Author Mary Soliel Receives Third National Book Award for Debut Non-Fiction on Synchronicity 3Health News:New Life Agency, Inc. Continues to Trial Against Beitler Services, Inc. in Pursuit of Payments for Surrogate Maternity Claims 2Health News:New Life Agency, Inc. Continues to Trial Against Beitler Services, Inc. in Pursuit of Payments for Surrogate Maternity Claims 3
(Date:4/16/2015)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), a ... products for the treatment of central nervous system disorders, ... quarter of 2015 on Wednesday, May 6, 2015, after ... host a conference call at 4:30 PM ET on ... discuss the first quarter 2015 financial results and other ...
(Date:4/16/2015)... Mass. , April 16, 2015  Hologic, ... important cervical cancer screening study i published ... a peer-reviewed journal of the American Cancer Society. ... Diagnostics and the University of Pittsburgh Medical Center, supports current ... which recommend that women 30-65 years of age ...
(Date:4/16/2015)... 16, 2015 Mallinckrodt plc (NYSE: ... announced that it has completed its acquisition of ... $2.3 billion. The Ikaria acquisition extends Mallinckrodt,s footprint ... into neonatal critical care with INOMAX ® ... a highly vulnerable patient population. It also accelerates ...
Breaking Medicine Technology:Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 2Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 3Hologic Comments on Important Cervical Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology 4Mallinckrodt Completes Acquisition Of Ikaria 2Mallinckrodt Completes Acquisition Of Ikaria 3Mallinckrodt Completes Acquisition Of Ikaria 4Mallinckrodt Completes Acquisition Of Ikaria 5
... 20, 2011 The Society ... safety, taking a leading role in measuring and assessing ... protection and reduction of skin dosage; and promoting the ... published this month in the Journal of Vascular and ...
... 2011 Vista Partners announced today that it ... OPXA ) ("the Company")and maintains its twelve month ... Partners stated, "According to the Company, Opexa,s lead clinical candidate ... Multiple sclerosis , is scheduled to advance into a pivotal ...
Cached Medicine Technology:Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 2Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 3Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 4Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices 5Vista Partners Updates Coverage on Opexa Therapeutics, Inc.; Maintains Target Price of $6.50 2
... The PipetBoy Pipettor is light as a feather ... aspiration speed can be continuously adjusted. The pipette ... be autoclaved. Two dosing knobs enable fine dosing ... plastic an/or glass pipettes from 0.1 to 100 ...
Precise, safe, and fatigue-free series pipetting using graduated pip...
Inquire...
Inquire...
Medicine Products: